Get the Stockscreener App
1.94
8.49%
-0.18
After Hours:
1.97
0.03
+1.55%
Palisade Bio Inc stock is traded at $1.94, with a volume of 5.44M.
It is down -8.49% in the last 24 hours and up +125.66% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$2.12
Open:
$2
24h Volume:
5.44M
Relative Volume:
0.68
Market Cap:
$17.69M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.1387
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
+9.60%
1M Performance:
+125.66%
6M Performance:
+149.97%
1Y Performance:
-37.42%
1-Day Range:
$1.92
$2.115
1-Week Range:
$1.61
$2.14
52-Week Range:
$0.53
$3.30
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.94 | 282.39M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.89 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.04 | 68.62B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.56 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
820.36 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.22 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Palisade Bio Inc Stock (PALI) Latest News
Using data filters to optimize entry into Palisade Bio Inc.Gap Down & Comprehensive Market Scan Reports - newser.com
How to track smart money flows in Palisade Bio Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Will Palisade Bio Inc. stock benefit from AI adoptionWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Should I hold or sell Palisade Bio Inc. stock in 2025Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Can volume confirm reversal in Palisade Bio Inc.Volume Spike & Reliable Price Action Trade Plans - newser.com
Palisade Bio’s Unexpected Surge: Analyzing Recent Developments - StocksToTrade
Palisade Bio Inc. recovery potential after sell offJuly 2025 Sector Moves & Real-Time Chart Pattern Alerts - newser.com
Palisade Bio appoints Sharon Skare as VP of global clinical operations - Investing.com Australia
Palisade Bio Inc. stock momentum explainedTrade Analysis Report & Weekly Momentum Picks - newser.com
Forecasting Palisade Bio Inc. price range with options dataJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Palisade Bio Inc Stock Analysis and ForecastTrading Volume Surges & Access High Yield Alerts - earlytimes.in
Will Palisade Bio Inc. stock maintain momentum in 2025July 2025 Intraday Action & Community Consensus Trade Signals - Fundação Cultural do Pará
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations - The Manila Times
Palisade Bio (NASDAQ: PALI) appoints Sharon Skare; IND planned H1 2026 for PALI-2108 - Stock Titan
What sentiment indicators say about Palisade Bio Inc. stockRecession Risk & Precise Buy Zone Tips - newser.com
Automated trading signals detected on Palisade Bio Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
Is Palisade Bio Inc. stock attractive for retirement portfoliosTake Profit & Safe Capital Growth Trade Ideas - newser.com
What MACD and RSI say about Palisade Bio Inc.Weekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Is Palisade Bio Inc. stock trading near support levels2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
Is Palisade Bio Inc. stock vulnerable to regulatory risks2025 Retail Activity & Stock Portfolio Risk Management - Fundação Cultural do Pará
Breakout Watch: What sentiment indicators say about Palisade Bio Inc. stockWeekly Earnings Recap & Free Accurate Trade Setup Notifications - Fundação Cultural do Pará
Why Palisade Bio Inc. (7NS0) stock could outperform next yearQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Palisade Bio Inc Stock (PALI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wei Binxian | Director |
Nov 21 '24 |
Option Exercise |
0.00 |
388 |
0 |
855 |
0.74%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):